{"name":"Inmune Bio, Inc.","slug":"inmune-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNN3RfRmI1a2xUNFVTcFNMWjlGSXM0Mi1LQUstV2FTSjhmdncyWmtmRl9BRmxuTWVJcUt2MkcyeENISUJudW1lRDBMQWE0dmxEYVhHT0NUNk9scUh6cXZMQmpLTG1FMnZoN2xQcHROUjVKdjhmRDhBRm1hSVRWdlNLQWFGY1ZIT1IzemNjSkx3a1IwVW5IM1VlYThzdFU4WjBuVnpR?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"Pipeline reset at INmune Bio (NASDAQ: INMB) after CORDStrom gains and XPro setback - Stock Titan","headline":"Pipeline reset at INmune Bio (NASDAQ: INMB) after CORDStrom gains and XPro setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQSkFHT2JwZGZXUG1TY0RrcjRJcDhpYlVGTDU2U2ZleWtpVDFIRmgwd1dZTDVqeUhXck0zMU9HZFd2WmNKZzMwM3QwbzRMc0s4RXpIVDZHOERTV2ZDempXbGRiYXRMNXFWQXc2UjBMLUhIcjlCVWhHclBYSjhqMEpMbm1qazZlcVQ0Vk9RWXhpNC05c282S3NvUDc1Uy1yajg?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance","summary":"INmune Bio Inc. Announces 2025 Results and Provides Business Update - Yahoo Finance","headline":"INmune Bio Inc. Announces 2025 Results and Provides Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPRFVKZDFQRlFKdk5rVm5ybjZacjdkam9Pa0hHRmNtQktUTW8zVVV1Z1JmQ3RqbU1xel9Oa0JIV3J1Qlk3THV2Q1MtRGVMdHJsZ2dXSkhjTFdiV2xFMmZNMFFOVzQ1a25hcmUtZnJ5cDYtZzU0akQ2RVpTWWtOLUVmOGdJNnlKRHZ4SXpxZkdvVUUzVFpTbmZoSHZrVWxYLXBHd1A2cW1vSGMtZTdqdjAxOHRzTGNtcTdPa3FCV3h3?oc=5","date":"2026-03-16","type":"pipeline","source":"AD HOC NEWS","summary":"INmune Bio Inc Stock (ISIN: US45764T1060) Faces Analyst Hold Consensus Amid $8 Price Target - AD HOC NEWS","headline":"INmune Bio Inc Stock (ISIN: US45764T1060) Faces Analyst Hold Consensus Amid $8 Price Target","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-26","type":"pipeline","source":"simplywall.st","summary":"INmune Bio's US$7.7m Market Cap Fall Books Insider Losses - simplywall.st","headline":"INmune Bio's US$7.7m Market Cap Fall Books Insider Losses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQMUhNTDhZQmV1X2N4T3FFNGJDSlcwUDliS28wWTd1SnhRLTNWQm04Rnp4d2VzT191SElxQTc1ODd2WWllX0s3a0JBZFIzTjZtMGRnVWNTTzhpamxMb3Joa2RBNkYtNGsyLXJBLTJXTGRjcEljakd5NE1TZXhDZFp0ZjNTU1p5Y3Y5QUVObDZIOFo1MWM?oc=5","date":"2025-08-07","type":"trial","source":"CGTLive®","summary":"INmune Bio's INKmune Hits End Points in mCR Prostate Cancer Trial - CGTLive®","headline":"INmune Bio's INKmune Hits End Points in mCR Prostate Cancer Trial - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPVEFncWFvTkVYbzZCMS12am84d3RYeTZoUU1kaWpBdzZ0WUp3N1BEZ2hxbV94NmhTS0Q5RW90NEFrRjRWRHNUX1V6by1LWEowZ05JT3BuOHM4NF9PblZRand4WWtDR0JZbmRBLVlwWkNYN0ZQdmwzUlpfX3BRVURzVGR0M21OYXdrc25HNTZvTm5kQWI0cEdQcnZiamtSeTAzVW9xOQ?oc=5","date":"2025-08-04","type":"trial","source":"Urology Times","summary":"Phase 1/2 trial of INKmune therapy for mCRPC meets primary end point - Urology Times","headline":"Phase 1/2 trial of INKmune therapy for mCRPC meets primary end point","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOQlJWeUtPSmYzeHlJN2ZrVU5lZXFyb3RBUUxTTmRGNHM2VVc2a3ZPTW9QaW5VU0dicnRQU0FMQlRyY1JRTG9OTUJEQzNhUC05azkxTWptT2NvdzZxNUJqMFh4aUNQOWN6bERtcEtKSVNncGhvem8tNW9wZkc0TEhlT0NESTM1ajF5a0w5UnpDZ21FYXNWa0wzd2tXSm1Ed2o1YkpQWnhlRW1ldjRHWXdWWXB2YUpjeEx0SWFqcElnRnhmc2ZUYTRKbWNnNHRJVEE?oc=5","date":"2025-07-04","type":"pipeline","source":"Sahm","summary":"'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday - Sahm","headline":"'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYmVzVGRWLXZxNldtWHlDNFJsY00yaHdESWxfcVI4RWxId1JZN2VHSGY0UkNVYUVPVGVidF9rWFNDSl9zYU84dVdhc0lCa2x4X2dzX0wzWkVmSlFlQ2cwSF8yLWp5NDNDckxIRmtOTTNIa0JBTlFSXzZmd2hQcXpmZGN3?oc=5","date":"2025-07-02","type":"pipeline","source":"Seeking Alpha","summary":"INmune Bio Stock: What's Left For Investors (NASDAQ:INMB) - Seeking Alpha","headline":"INmune Bio Stock: What's Left For Investors (NASDAQ:INMB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQUk9nZmNPVkhSUVZ3WGFIV19NbHEzeGE5Z1E4RDRYOEx2M01GTU41aldnUXh0ZkVrX0FGQlNRTnFYajhVbVhEVnZKUldOeXNHQVByMUN5cU9xOWM4UXpOSUNPaHRaN0pJSkxSRWdVbV8wMl9kSUpzeURWR1UtWW1tTktOM0x3MXFwbjR1bXd5N0s3T0t3eTZqcEMyand1aUJweFpiSWRKRW5Rc2gwNW1FWDEzYWJ1RlBwRlBoUS1qRGstLWFQVlZIa1pGMTFaeDMzN0E?oc=5","date":"2025-06-30","type":"pipeline","source":"Reuters","summary":"INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low - Reuters","headline":"INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB3S3lubEM3VjhERC13dDhWbGZmUUpnX0tpUVhoUlZsbURnaVprRGdhbWdObUNMNjhldzlEeWZ0Z2QxbTY3VUlMTnJ5eTZMVEFRc0M0?oc=5","date":"2025-06-30","type":"trial","source":"FirstWord Pharma","summary":"INmune Bio hails 'win' despite TNF inhibitor failing key early Alzheimer's study - FirstWord Pharma","headline":"INmune Bio hails 'win' despite TNF inhibitor failing key early Alzheimer's study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNcy1kNFB1NEl3RzEzRUlOVmlkRFB5M1hKVEs5VHcyYkRoX2pmVUxZVXgzNk5tVTljbGw1Y19ta2hnaHNhZE1yTng4UjFYb0p1ZTc4SEFqc2xsa2VzS3lUazJHaWlmUXpjVGdOc0I5VGk0M0g4X1JPZm90eW4tTEx3RE5pb2hXUms5S3A3cXJfbU1tWFdQZ0g4aFAzTDRVS3VtZ2E2TEZ3cmtLNElQ?oc=5","date":"2025-06-16","type":"trial","source":"Seeking Alpha","summary":"INmune Bio: Imminent Phase 2 Alzheimer's Readout Of Unique Asset Presents Interesting Speculative Opportunity - Seeking Alpha","headline":"INmune Bio: Imminent Phase 2 Alzheimer's Readout Of Unique Asset Presents Interesting Speculative Opportunity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNSUs2eE1sWVZEQUlXVi1tb3FoOHgtSWoyWHhVSnpabDllOGFvRnNKUnpOLU1FR3o0VWllRWFzMk1hd0J4RVBsUkV0NzFHTWtGQjNINnU1VDVsRWtJdlhuc3JvUkRQZDYtaTRpRjBnVnhqcS1XSDdpTW1FTExmZ3ZPdTVHYWtqZDZKZ2ZIdWFEbXBnQ29WMTdsX2kzdG5PMmJBcmZrVTZaMkVpWWhKNXpCdktzMk9LeFVMeVFqQU1NSy1kTHdjSHE2WlBlaFAzRTJpWVlmczhoN0RpV2xsLUt5djJtVEdSOWJBVE5wMHVZcmJNbW9VRVRydVJQUGJmMHFNMDdfcGRRNE9DOUFNel9hV2ZWeHV2aVo0MWIxWGlVRkI?oc=5","date":"2024-12-04","type":"trial","source":"businesswire.com","summary":"OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower - businesswire.com","headline":"OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}